metyrapone has been researched along with Hodgkin Disease in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, E | 1 |
| Bossolo, PA | 1 |
| Pallavicini, S | 1 |
| Personeni, G | 1 |
| Cushman, P | 1 |
2 other studies available for metyrapone and Hodgkin Disease
| Article | Year |
|---|---|
[Corticotropo-corticoadrenal dynamics in prolonged cortisone treatment].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotr | 1967 |
ACTH release in response to metyrapone in diabetes insipidus patients.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Craniocerebral Trauma; Diabetes Insipidus; Female; G | 1968 |